Cleavage

Cleavage is a metabolic reaction in which a specific chemical bond is broken, splitting one molecule into two distinct fragments. In pharmacology, this most often means hydrolytic cleavage — the addition of a water molecule across an ester, amide, phosphate, or glucuronide bond — though reductive cleavage and other mechanisms occur as well.

The term surfaces in two closely related contexts on these pages: as a step in how the body transforms a substance through biotransformation, and as a deliberate analytical step that drug-testing laboratories perform to reveal conjugated metabolites that would otherwise fall below detection thresholds.

How it works · its role

Hydrolytic cleavage works by inserting a water molecule across a target bond. Each resulting fragment retains one part of that water. An ester bond splits into a carboxylic acid and an alcohol; a phosphate ester releases inorganic phosphate; a glucuronide conjugate yields the free drug or metabolite plus glucuronic acid.

Several enzyme families carry out cleavage in the body. Esterases — including plasma esterases and liver carboxylesterases — handle ester bonds. Alkaline phosphatases cleave phosphate groups. Beta-glucuronidase, found in the gut, liver, and certain gut bacteria, cleaves the glucuronide tags that Phase II metabolism attaches to lipophilic molecules to render them water-soluble and excretable.

In the laboratory, a technician adds beta-glucuronidase to a urine sample before running the assay. This enzymatic step frees conjugated metabolites from their glucuronide carriers, raising their measurable concentration and revealing compounds that analyses run without hydrolysis might miss entirely.

Relevance to substances & effects

Cleavage explains why many substances do not arrive at their receptors in the form they were consumed. Prodrugs are intentionally designed around this principle — inactive as ingested, they become pharmacologically active only after cleavage in the body.

Psilocybin is a well-studied example: alkaline phosphatase cleaves its phosphate group shortly after ingestion, yielding psilocin — the compound that activates 5-HT₂A receptors and produces psychedelic effects. The rate of that dephosphorylation step contributes to how gradually onset unfolds compared with directly active tryptamines.

Heroin (diacetylmorphine) follows a different arc: plasma esterases and tissue enzymes cleave its two acetyl ester bonds in sequence, producing 6-monoacetylmorphine and then morphine. The acetyl groups serve a fast-entry function across the blood–brain barrier; cleavage converts the molecule into the form opioid receptors recognise.

Cocaine's short plasma half-life reflects the same mechanism — esterases rapidly cleave its ester bonds, disposing of it far faster than stimulants that lack them. The ester-type local anesthetics (procaine, benzocaine, tetracaine) are metabolised identically, which is why they are clinically distinct from amide-type agents such as lidocaine, whose bonds plasma esterases cannot cleave.